Total Holdings
62
Portfolio diversification across 62 positions
BMED
(NYSEARCA)iShares Health Innovation Active ETF
$34.59-- (--)
Loading... - Market loading
BMED ETF Holdings: iShares Health Innovation Active ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$11.29M
Total fund assets
Expense Ratio
0.55%
Annual management fee
Fund Issuer
BlackRock
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 49 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Merck & Co., Inc | Stock | 5.82% |
| 2 |  | Gilead Sciences, Inc | Stock | 5.11% |
| 3 |  | Edwards Lifesciences Corporation | Stock | 4.53% |
| 4 |  | Johnson & Johnson | Stock | 4.40% |
| 5 |  | Thermo Fisher Scientific Inc | Stock | 3.97% |
| 6 |  | Danaher Corporation | Stock | 3.84% |
| 7 |  | Charles River Laboratories International, Inc | Stock | 3.68% |
| 8 |  | Biogen Inc | Stock | 3.64% |
| 9 |  | Waters Corporation | Stock | 3.53% |
| 10 |  | AbbVie Inc | Stock | 3.50% |
| 11 |  | Amgen Inc | Stock | 3.50% |
| 12 |  | Moderna, Inc | Stock | 3.38% |
| 13 |  | Mettler-Toledo International Inc. | Stock | 3.30% |
| 14 |  | Illumina, Inc. | Stock | 3.22% |
| 15 |  | Vertex Pharmaceuticals Incorporated | Stock | 3.02% |
| 16 |  | Bio-Techne Corporation | Stock | 2.46% |
| 17 |  | DexCom, Inc | Stock | 2.45% |
| 18 |  | Neurocrine Biosciences, Inc. | Stock | 2.20% |
| 19 | S SWX:NOVN | Novartis AG | Stock | 2.17% |
| 20 | S SWX:ROP | Roche Holding AG | Stock | 2.00% |
| 21 |  | argenx NV ADR | Stock | 1.93% |
| 22 | X XTSLA | BLK CSH FND TREASURY SL AGENCY | Stock | 1.89% |
| 23 |  | Cytokinetics, Incorporated | Stock | 1.88% |
| 24 |  | IQVIA Holdings Inc | Stock | 1.76% |
| 25 |  | Incyte Corporation | Stock | 1.73% |
| 26 |  | Abbott Laboratories | Stock | 1.60% |
| 27 |  | Guardant Health, Inc | Stock | 1.47% |
| 28 | E EBR:UCB | UCB SA | Stock | 1.44% |
| 29 |  | Roivant Sciences Ltd | Stock | 1.42% |
| 30 |  | Axsome Therapeutics, Inc | Stock | 1.39% |
| 31 | L LSE:AZN | AstraZeneca PLC | Stock | 1.33% |
| 32 |  | BioMarin Pharmaceutical Inc | Stock | 1.23% |
| 33 | H HKG:2269 | WuXi Biologics | Stock | 1.20% |
| 34 |  | Bristol-Myers Squibb Company | Stock | 1.18% |
| 35 |  | Revolution Medicines, Inc | Stock | 1.17% |
| 36 |  | Bruker Corporation | Stock | 0.98% |
| 37 |  | Protagonist Therapeutics Inc | Stock | 0.93% |
| 38 |  | Alkermes plc | Stock | 0.80% |
| 39 |  | Apogee Therapeutics, Inc. Common Stock | Stock | 0.70% |
| 40 |  | Intuitive Surgical, Inc | Stock | 0.68% |
| 41 |  | Arcus Biosciences, Inc | Stock | 0.62% |
| 42 |  | BioNTech SE | Stock | 0.58% |
| 43 |  | Dianthus Therapeutics Inc. | Stock | 0.56% |
| 44 |  | MBX | Stock | 0.52% |
| 45 |  | Insmed Incorporated | Stock | 0.48% |
| 46 |  | Erasca Inc | Stock | 0.41% |
| 47 |  | Avalo Therapeutics Inc | Stock | 0.13% |
| 48 |  | Ultragenyx Pharmaceutical Inc | Stock | 0.13% |
| 49 |  | Sagimet Biosciences Inc. | Stock | 0.12% |
Frequently Asked Questions About iShares Health Innovation Active ETF Holdings
What are the top holdings in BMED?
iShares Health Innovation Active ETF (BMED) holds 62 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is BMED's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review BMED's holdings table to analyze concentration risk.
What is BMED's sector allocation?
The Sector Allocation chart shows how BMED distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does BMED invest in?
BMED's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is BMED ETF?
BMED's diversification can be assessed by reviewing its 62 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.